相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Karl Bjorkstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial
Mads J. Skytte et al.
DIABETOLOGIA (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
Oana P. Zaharia et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Jinhua Yan et al.
HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
Elliot B. Tapper et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
NHS lacks the resources to keep re-testing for non-alcoholic fatty liver disease
Nicholas Sharvill
BMJ-BRITISH MEDICAL JOURNAL (2018)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas et al.
JOURNAL OF HEPATOLOGY (2017)
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus A meta-analysis
Wenjie Dai et al.
MEDICINE (2017)
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
Emilie Blond et al.
DIABETOLOGIA (2017)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
Sarah H. Wild et al.
JOURNAL OF HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou et al.
LANCET (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
Lisa M. Glass et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Determination of reliability criteria for liver stiffness evaluation by transient elastography
Jerome Boursier et al.
HEPATOLOGY (2013)
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
Kate Hallsworth et al.
GUT (2011)
Randomized Comparison of Reduced Fat and Reduced Carbohydrate Hypocaloric Diets on Intrahepatic Fat in Overweight and Obese Human Subjects
Sven Haufe et al.
HEPATOLOGY (2011)
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors
Nathalie C. Leite et al.
LIVER INTERNATIONAL (2011)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2010)
Independent Effects of Physical Activity in Patients with Nonalcoholic Fatty Liver Disease
Alexis St. George et al.
HEPATOLOGY (2009)
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Srinivasan Dasarathy et al.
JOURNAL OF HEPATOLOGY (2009)
Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients
Steina Aradottir et al.
ALCOHOL AND ALCOHOLISM (2006)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
分享论文
